CareDx, Inc. (CDNA)
77.88
-1.93
(-2.42%)
USD |
NASDAQ |
Nov 13, 16:00
77.00
-0.88
(-1.13%)
After-Hours: 19:59
CareDx Net Income (Quarterly) : 19.29M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 19.29M |
| June 30, 2026 | 110.64M |
| March 31, 2026 | 2.809M |
| December 31, 2025 | -4.108M |
| September 30, 2025 | 1.675M |
| June 30, 2025 | -8.568M |
| March 31, 2025 | -10.35M |
| December 31, 2024 | 87.70M |
| September 30, 2024 | -10.64M |
| June 30, 2024 | -4.623M |
| March 31, 2024 | -19.89M |
| December 31, 2023 | -118.10M |
| September 30, 2023 | -23.48M |
| June 30, 2023 | -24.95M |
| March 31, 2023 | -23.75M |
| December 31, 2022 | -18.33M |
| September 30, 2022 | -16.94M |
| June 30, 2022 | -21.70M |
| March 31, 2022 | -19.65M |
| December 31, 2021 | -16.15M |
| September 30, 2021 | -11.90M |
| June 30, 2021 | -1.927M |
| March 31, 2021 | -0.687M |
| December 31, 2020 | -3.515M |
| September 30, 2020 | -2.818M |
| Date | Value |
|---|---|
| June 30, 2020 | -6.558M |
| March 31, 2020 | -5.823M |
| December 31, 2019 | -4.777M |
| September 30, 2019 | -1.813M |
| June 30, 2019 | -7.847M |
| March 31, 2019 | -7.531M |
| December 31, 2018 | -3.755M |
| September 30, 2018 | -19.97M |
| June 30, 2018 | -14.06M |
| March 31, 2018 | -8.994M |
| December 31, 2017 | -31.63M |
| September 30, 2017 | -14.29M |
| June 30, 2017 | -4.035M |
| March 31, 2017 | -5.609M |
| December 31, 2016 | -15.71M |
| September 30, 2016 | -3.799M |
| June 30, 2016 | -10.49M |
| March 31, 2016 | -9.752M |
| December 31, 2015 | -4.762M |
| September 30, 2015 | -3.489M |
| June 30, 2015 | -3.185M |
| March 31, 2015 | -2.272M |
| December 31, 2014 | -0.005M |
| September 30, 2014 | 1.213M |
| June 30, 2014 | 0.877M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Natera, Inc. | -59.91M |
| Myriad Genetics, Inc. | -43.90M |
| BioRestorative Therapies, Inc. | -2.154M |
| Exagen, Inc. | -6.336M |
| Sera Prognostics, Inc. | -8.053M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 139.36M |
| Total Expenses (Quarterly) | 120.07M |
| EPS Diluted (Quarterly) | 0.3509 |
| Enterprise Value | 3.864B |
| Gross Profit Margin (Quarterly) | 70.51% |
| Profit Margin (Quarterly) | 13.84% |
| Earnings Yield | 3.07% |
| Operating Earnings Yield | 0.10% |
| Normalized Earnings Yield | 3.087 |